Discover
LFCR
Lifecore Biomedical, Inc.
4.83
10 x 4.82
5 x 4.84
bid
ask
+
0.17
3.65%
2 @ 04:00 PM
4.83 +0.00 (0.00%)
| Ytd | -40.95% | |
| 1y | -33.10% |
4.67
day range
4.96
3.63
52 week range
8.98
| Open | 4.72 | Prev Close | 4.66 | Low | 4.67 | High | 4.96 | Mkt Cap | 181.17M |
| Vol | 0.00 | Avg Vol | 194.10K | EPS | -1.07 | P/E | -4.51 | Forward P/E | -9.90 |
| Beta | 0.94 | Short Ratio | 11.20 | Inst. Own | 69.84% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 5.01 | 200-d Avg | 6.18 | 1yr Est | 8.00 |
| Income Statement | |||
| Total Revenue | 34.17M | ||
| Revenues (USD) | 34.17M | ||
| Cost of Revenue | 22.09M | ||
| Gross Profit | 12.08M | ||
| Operating Expenses | 9.51M | ||
| Research and Development Expense | 1.54M | ||
| Selling, General and Administrative Expense | 7.97M | ||
| Operating Income | 2.57M | ||
| Interest Expense | 7.75M | ||
| Income Tax Expense | 23.00K | ||
| Net Income | -6.16M | ||
| Net Income Common Stock | -7.13M | ||
| Net Income Common Stock (USD) | -7.13M | ||
| Consolidated Income | -6.16M | ||
| Earnings per Basic Share | -0.19 | ||
| Earnings per Basic Share (USD) | -0.19 | ||
| Earnings per Diluted Share | -0.19 | ||
| Earning Before Interest & Taxes (EBIT) | 1.62M | ||
| Earning Before Interest & Taxes (USD) | 1.62M | ||
| Preferred Dividends Income Statement Impact | 971.00K | ||
| Weighted Average Shares | 37.57M | ||
| Weighted Average Shares Diluted | 37.57M | ||
| Balance Sheet | |||
| Cash and Equivalents | 17.24M | ||
| Cash and Equivalents (USD) | 17.24M | ||
| Trade and Non-Trade Receivables | 30.46M | ||
| Current Assets | 83.69M | ||
| Property, Plant & Equipment Net | 123.71M | ||
| Total Assets | 229.50M | ||
| Total Debt | 154.10M | ||
| Current Liabilities | 21.64M | ||
| Debt Non-Current | 154.10M | ||
| Total Liabilities | 213.41M | ||
| Accumulated Retained Earnings (Deficit) | -244.34M | ||
| Shareholders Equity | -34.09M | ||
| Shareholders Equity (USD) | -34.09M | ||
| Assets Non-Current | 145.81M | ||
| Total Debt (USD) | 154.10M | ||
| Goodwill and Intangible Assets | 13.88M | ||
| Inventory | 25.48M | ||
| Liabilities Non-Current | 191.77M | ||
| Trade and Non-Trade Payables | 7.53M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.52M | ||
| Net Cash Flow from Financing | -852.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.55M | ||
| Capital Expenditure | -513.00K | ||
| Issuance (Purchase) of Equity Shares | -614.00K | ||
| Net Cash Flow from Investing | -513.00K | ||
| Net Cash Flow from Operations | -2.19M | ||
| Share Based Compensation | 2.09M | ||